Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years, notes Bhupesh Bhandari The Ranbaxy affair is one of the darkest chapters of......
There is a global movement towards generics and every patent-driven company wants a piece of the action, says Bhupesh Bhandari. In Sun Pharma's acquisition of Ranbaxy, what seems to have caught......
The company’s reputation has taken such a beating in the last few months that any attempt at image management will be an uphill task, says Bhupesh Bhandari. Yet another factory of......
If Ranbaxy had to survive, it would have to grow abroad, induct professionals and invest in research, notes Bhupesh Bhandari Ranbaxy tasted success for the first time in the 1960s with its......
There are two pharmaceutical industries in India -The first sells its produce in large volumes in quality-conscious United States, the gold standard, while the second sells chalta hai......